1. Digitum: Repositorio Institucional de la Universidad de Murcia

Buscar por Materia Prostate cancer

Ir a una fecha de inicio:
Mostrando resultados 1 a 20 de 24  Siguiente >
Vista previaFecha de publicaciónFecha de CreaciónTítulo
Grading of the prostate carcinoma cytohistological correlations on 100 cases.pdf.jpg1986-Grading of the prostate carcinoma, cyto-histological correlations on 100 cases
Etoposide sensitivity of human prostatic cancer cell lines PC3 DU 145 and LNCaP.pdf.jpg1999-Etoposide sensitivity of human prostatic cancer cell lines PC-3, DU 145 and LNCaP
Cell proliferation and apoptosis in prostate cancer. significance in disease progression and therapy.pdf.jpg2000-Cell proliferation and apoptosis in prostate cancer. significance in disease progression and therapy
Molecular therapeutics in prostate cancer.pdf.jpg2003-Molecular therapeutics in prostate cancer
Neuropeptides apoptosis and ion changes in prostate.pdf.jpg2004-Neuropeptides, apoptosis and ion changes in prostate cancer. Methods of study and recent developments
Hepatocyte growth factor scatter.pdf.jpg2005-Hepatocyte growth factor/scatter factor and prostate cancer: a review
Study of microvessel density and the expression of the angiogenic factors VEGF bFGF and the receptors Flt1 and FLK1 in benign premalignant and.pdf.jpg2006-Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues
Bone morphogenetic proteins and their receptor signaling in prostate cancer.pdf.jpg2007-Bone morphogenetic proteins and their receptor signaling in prostate cancer
SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation.pdf.jpg2008-SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation
Diagnostic and prognostic value of.pdf.jpg2010-Diagnostic and prognostic value of T-cell receptor gamma alternative reading frame protein (TARP) expression in prostate cancer
Fernandez-Martinez-27-1093-1101-2012.pdf.jpg2012-Overexpression of vasoactive intestinal peptide receptors and cyclooxygenase-2 in human prostate cancer. Analysis of potential prognostic relevance
Liu-28-1621-1628-2013.pdf.jpg2013-Dendritic and lymphocytic cell infiltration in prostate carcinoma
Jemaa-29-1263-1280-2014.pdf.jpg2014-Insight into the heterogeneity of prostate cancer through PSA-PSMA prostate clones: mechanisms and consequences
Ren-29-535-542-2014.pdf.jpg2014-Prognostic impact of NDRG2 and NDRG3 in prostate cancer patients undergoing radical prostatectomy
Soares-30-1143-1154-2015.pdf.jpg2015-Anticancer properties of carotenoids in prostate cancer. A review
Su-31-149-157-2016.pdf.jpg2016-Notch signaling in prostate cancer: refining a therapeutic opportunity
336781-Texto del artículo-1225051-1-10-20190219.pdf.jpg2019-Cáncer de próstata: conocimientos e interferencias enla promoción y prevención de la enfermedad
Zhang-35-827-831-2020.pdf.jpg2020-Prognostic value of microRNA-20b expression level in patients with prostate cancer
An-37-597-607-2022.pdf.jpg2022-Fibroblast activation protein-alpha knockdown suppresses prostate cancer cell invasion and proliferation
Chen-37-423-430-2022.pdf.jpg2022-Downregulation of miR-485-3p promotes proliferation, migration and invasion in prostate cancer through activation of TGF-β signaling
Mostrando resultados 1 a 20 de 24  Siguiente >